http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5185341-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-545 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1991-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb7e0933b8792ce8683b96dc6fd7cc8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba56ba3fe6fab74b7966784d4034795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee8382475ad16b4ad0c72c66e2d83dd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49bc7754f41aaf295cb749149f4db303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a4bbf5d9cd1a94d257289937337446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d037b831d79d592c9c92362596cbe430 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6902b075280bbf6d01997bcc278f7093 |
| publicationDate | 1993-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5185341-A |
| titleOfInvention | Substituted 5-(phenoxyalkanoylamino)-uracil compounds, methods for making same and pharmaceutical compositions based on same |
| abstract | The substituted 5-(phenoxyalkanoylamino)-uracil compounds have the following formula I: <IMAGE> I wherein R1 and R2 are each independently hydrogen; a branched or linear alkyl group having 1 to 6 carbon atoms; a branched or straight chain alkenyl or alkynyl group having 1 to 6 carbons atoms; a cycloalkyl group having from 3 to 7 carbon atoms or a cycloalkylmethyl group having a cycloalkyl residue of 3 to 7 carbon atoms; or a phenylalkyl group having an alkyl residue having from 1 to 3 carbon atoms and a phenyl residue, the phenyl residue being unsubstituted or having a halogen, methoxy, methyl or trifluoromethyl substituent; R3 is a hydrogen, methyl or amino groups; R4 is halogen, methoxy or methyl groups, and n is 1 or 2. Pharmaceutical compositions for treating cerebrovascular, neuronal-degenerative and senility-induced disorders associated with learning, memory and cognitive dysfunctions are described which contain a therapeutically effective amount of the substituted 5-(phenoxyalkanoylamino)-uracil in a pharmaceutically acceptable carrier. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939419-A |
| priorityDate | 1990-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.